Pub. Date : 2014 Jan
PMID : 24170769
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Unfortunately, as with other RAF inhibitors, patients treated with sorafenib have a 5% to 10% rate of developing cutaneous squamous cell carcinoma (cSCC)/keratoacanthomas. | Sorafenib | zinc fingers and homeoboxes 2 | Homo sapiens |